In addition, detailed analysis of breast cancer data showed that low Claspin expression was associated with reduced survival, but only in patients who concomitantly presented with TP53 mutations, whereas the opposite was found in patients with wt TP53. This evidence concerns the gene TP53 and breast cancer.